Molecular mechanisms of helicobacter pylori pathogenesis

Journal of Cellular Physiology

Volumn 230, Issue 8, 2015, Pages 1702-1707

  De Falco, Maria ^a,b   Lucariello, Angela ^c   Iaquinto, Salvatore ^d   Esposito, Vincenzo ^e   Guerra, Germano ^f   De Luca, Antonio ^c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d SAN FILIPPO NERI HOSPITAL   (Italy)

^e AO Dei Colli Hospital for Infectious Diseases D Cotugno   (Italy)

^f UNIVERSITY OF MOLISE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE; VIRULENCE FACTOR;

BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; CELL ACTIVATION; CELL ADHESION; DNA METHYLATION; DNA MODIFICATION; EPIGENETICS; EPITHELIUM CELL; GENE EXPRESSION; HELICOBACTER INFECTION; HUMAN; INFLAMMATORY CELL; NONHUMAN; PATHOGENESIS; PATHOGENICITY ISLAND; PRECANCER; PRIORITY JOURNAL; REVIEW; STOMACH EPITHELIUM; SURVIVAL RATE; TUMOR SUPPRESSOR GENE; ANIMAL; COMPLICATION; HELICOBACTER PYLORI; PATHOGENICITY; PATHOPHYSIOLOGY; PHYSIOLOGY;

BACTERIA (MICROORGANISMS); HELICOBACTER PYLORI;

ANIMALS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS;

EID: 84928396899     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24933     Document Type: Review

References (104)

1. Alm RA, Trust TJ. 1999. Analysis of the genetic diversity of Helicobacter pylori: The tale of two genomes. J Mol Med 77:834-846.
2. Alvarez MC, Ladeira MS, Scaletsky IC, Pedrazzoli J, Jr., Ribeiro ML. 2013a. Methylation pattern of THBS1, GATA-4, and HIC1 in pediatric and adult patients infected with Helicobacter pylori. Dig Dis Sci 58:2850-2857.
3. Alvarez MC, Santos JC, Maniezzo N, Ladeira MS, da Silva AL, Scaletsky IC, Pedrazzoli J, Jr., Ribeiro ML. 2013b. MGMT and MLH1 methylation in Helicobacter pylori-infected children and adults. World J Gastroenterol 19:3043-3051.
4. Aspholm M, Olfat FO, Norden J, Sonden B, Lundberg C, Sjostrom R, Altraja S, Odenbreit S, Haas R, Wadstrom T, Engstrand L, Semino-Mora C, Liu H, Dubois A, Teneberg S, Arnqvist A, Boren T. 2006. SabA is the H. pylori hemagglutinin and is polymorphic in binding to sialylated glycans. PLoS Pathog 2:e110.
5. Baik SC, Kim KM, Song SM, Kim DS, Jun JS, Lee SG, Song JY, Park JU, Kang HL, Lee WK, Cho MJ, Youn HS, Ko GH, Rhee KH. 2004. Proteomic analysis of the sarcosine-insoluble outer membrane fraction of Helicobacter pylori strain 26695. J Bacteriol 186:949-955.
6. Bhaskar KR, Garik P, Turner BS, Bradley JD, Bansil R, Stanley HE, LaMont JT. 1992. Viscous fingering of HCl through gastric mucin. Nature 360:458-461.
7. Blaser MJ, Berg DE. 2001. Helicobacter pylori genetic diversity and risk of human disease. J Clin Invest 107:767-773.
8. Bonis M, Ecobichon C, Guadagnini S, Prévost M-C, Boneca IG. 2010. A M23B family metallopeptidase of Helicobacter pylori required for cell shape, pole formation and virulence. Mol Microbiol 78:809-819.
9. Boreiri M, Samadi F, Etemadi A, Babaei M, Ahmadi E, Sharifi AH, Nikmanesh A, Houshiar A, Pourfarzai F, Yazdanbod A, Alimohammadian M, Sotoudeh M. 2013. Gastric cancer mortality in a high incidence area: Long-term follow-up of Helicobacter pylori-related precancerous lesions in the general population. Arch Iran Med 16:343-347.
10. Buommino E, Donnarumma G, Manente L, De Filippis A, Silvestri F, Iaquinto S, Tufano MA, De Luca A. 2012. The Helicobacter pylori protein HspB interferes with Nrf2/Keap1 pathway altering the antioxidant response of Ags cells. Helicobacter 17:417-425.
11. Buti L, Spooner E, Van der Veen AG, Rappuoli R, Covacci A, Ploegh HL. 2011. Helicobacter pylori cytotoxin-associated gene A (CagA) subverts the apoptosis-stimulating protein of p53 (ASPP2) tumor suppressor pathway of the host. Proc Natl Acad Sci USA 108:9238-9243.
12. Celli JP, Turner BS, Afdhal NH, Keates S, Ghiran I, Kelly CP, Ewoldt RH, McKinley GH, So P, Erramilli S, Bansil R. 2009. Helicobacter pylori moves through mucus by reducing mucin viscoelasticity. Proc Natl Acad Sci USA 106:14321-14326.
13. Censini S, Lange C, Xiang Z, Crabtree JE, Ghiara P, Borodovsky M, Rappuoli R, Covacci A. 1996. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA 93:14648-14653.
14. Chan AO, Lam SK, Wong BC, Wong WM, Yuen MF, Yeung YH, Hui WM, Rashid A, Kwong YL. 2003. Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut 52:502-506.
15. Cheng AS, Li MS, Kang W, Cheng VY, Chou JL, Lau SS, Go MY, Lee CC, Ling TK, Ng EK, Yu J, Huang TH, To KF, Chan MW, Sung JJ, Chan FK. 2013. Helicobacter pylori causes epigenetic dysregulation of FOXD3 to promote gastric carcinogenesis. Gastroenterology 144:122-133.
16. Chiariotti L, Angrisano T, Keller S, Florio E, Affinito O, Pallante P, Perrino C, Pero R, Lembo F. 2013. Epigenetic modifications induced by Helicobacter pylori infection through a direct microbe-gastric epithelial cells cross-talk. Med Microbiol Immunol 202:327-337.
17. Cirak MY, Akyon Y, Megraud F. 2007. Diagnosis of Helicobacter pylori. Helicobacter 12:4-9.
18. Conlin VS, Curtis SB, Zhao Y, Moore ED, Smith VC, Meloche RM, Finlay BB, Buchan AM. 2004. Helicobacter pylori infection targets adherens junction regulatory proteins and results in increased rates of migration in human gastric epithelial cells. Infect Immun 72:5181-5192.
19. Correa P. 1992. Human gastric carcinogenesis: A multistep and multifactorial process-First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 52:6735-6740.
20. Crawford HC, Krishna US, Israel DA, Matrisian LM, Washington MK, Peek RM, Jr. 2003. Helicobacter pylori strain-selective induction of matrix metalloproteinase-7 in vitro and within gastric mucosa. Gastroenterology 125:1125-1136.
21. De Luca A, Iaquinto G. 2004. Helicobacter pylori and gastric diseases: A dangerous association. Cancer Lett 213:1-10.
22. De Luca A, Baldi A, Russo P, Todisco A, Altucci L, Giardullo N, Pasquale L, Iaquinto S, D'Onofrio V, Parodi MC, Paggi MG, Iaquinto G. 2003. Coexpression of Helicobacter pylori's proteins CagA and HspB induces cell proliferation in AGS gastric epithelial cells, independently from the bacterial infection. Cancer Res 63:6350-6356.
23. De Luca A, De Falco M, Iaquinto S, Iaquinto G. 2004. Effects of Helicobacter pylori infection on cell cycle progression and the expression of cell cycle regulatory proteins. J Cell Physiol 200:334-342.
24. De Luca A, De Falco M, Manente L, Dattilo D, Lucariello A, Esposito V, Gnarini M, Citro G, Baldi A, Tufano MA, Iaquinto G. 2008. Helicobacter pylori heat shock protein B (HspB) localizes in vivo in the gastric mucosa and MALT lymphoma. J Cell Physiol 216:78-82.
25. Delahay RM, Rugge M. 2012. Pathogenesis of Helicobacter pylori infection. Helicobacter 17:9-15.
26. Demirel BB, Akkas BE, Vural GU. 2013. Clinical factors related with Helicobacter pylori infection-Is there an association with gastric cancer history in first-degree family members? Asian Pac J Cancer Prev 14:1797-1802.
27. Dunn BE, Phadnis SH. 1998. Structure, function and localization of Helicobacter pylori urease. Yale J Biol Med 71:63-73.
28. Fichman S, Niv Y. 2004. Histological changes in the gastric mucosa after Helicobacter pylori eradication. Eur J Gastroenterol Hepatol 16:1183-1188.
29. Fox GJ, Wang CT, Parsonnet J. 2006. Helicobacter, chronic inflammation, and cancer. In: Hausen, ZH, editor. Infections, causing human cancer. Hoboken, NJ, USA: Wiley-VCH. pp 386-467.
30. Gerhard M, Lehn N, Neumayer N, Boren T, Rad R, Schepp W, Miehlke S, Classen M, Prinz C. 1999. Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc Natl Acad Sci USA 96:12778-12783.
31. Gobert AP, Mersey BD, Cheng Y, Blumberg DR, Newton JC, Wilson KT. 2002. Cutting edge: Urease release by Helicobacter pylori stimulates macrophage inducible nitric oxide synthase. J Immunol 168:6002-6006.
32. Goncalves IC, Magalhaes A, Fernandes M, Rodrigues IV, Reis CA, Martins MC. 2013. Bacterial-binding chitosan microspheres for gastric infection treatment and prevention. Acta Biomater 9:9370-9378.
33. Grady WM, Willis J, Guilford PJ, Dunbier AK, Toro TT, Lynch H, Wiesner G, Ferguson K, Eng C, Park JG, Kim SJ, Markowitz S. 2000. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet 26:16-17.
34. Hahm KB, Lee KJ, Kim JH, Cho SW, Chung MH. 1998. Helicobacter pylori infection, oxidative DNA damage, gastric carcinogenesis, and reversibility by rebamipide Dig Dis Sci 43:72S-77S.
35. Hnatyszyn A, Wielgus K, Kaczmarek-Rys M, Skrzypczak-Zielinska M, Szalata M, Mikolajczyk-Stecyna J, Stanczyk J, Dziuba I, Mikstacki A, Slomski R. 2013. Interleukin-1 gene polymorphisms in chronic gastritis patients infected with Helicobacter pylori as risk factors of gastric cancer development. Arch Immunol Ther Exp 61:503-512.
36. Honda M, Mori M, Ueo H, Sugimachi K, Akiyoshi T. 1996. Matrix metalloproteinase-7 expression in gastric carcinoma. Gut 39:444-448.
37. Iaquinto G, Todisco A, Giardullo N, D'Onofrio V, Pasquale L, De Luca A, Andriulli A, Perri F, Rega C, De Chiara G, Landi M, Taccone W, Leandro G, Figura N. 2000. Antibody response to Helicobacter pylori CagA and heat-shock proteins in determining the risk of gastric cancer development. Dig Liver Dis 32:378-383.
38. IARC. 1994. Schistosomes, liver flukes and Helicobacter pylori. Monographs on the evaluation of carcinogenic risks to humans. Lion, France: IARC Sci Publ. pp 1-241.
39. Ilver D, Arnqvist A, Ogren J, Frick IM, Kersulyte D, Incecik ET, Berg DE, Covacci A, Engstrand L, Boren T. 1998. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 279:373-377.
40. Jungblut PR, Bumann D, Haas G, Zimny-Arndt U, Holland P, Lamer S, Siejak F, Aebischer A, Meyer TF. 2000. Comparative proteome analysis of Helicobacter pylori. Mol Microbiol 36:710-725.
41. Kang HM, Kim N, Park YS, Hwang JH, Kim JW, Jeong SH, Lee DH, Lee HS, Jung HC, Song IS. 2008. Effects of Helicobacter pylori infection on gastric mucin expression. J Clin Gastroenterol 42:29-35.
42. Kaplan-Turkoz B, Jimenez-Soto LF, Dian C, Ertl C, Remaut H, Louche A, Tosi T, Haas R, Terradot L. 2012. Structural insights into Helicobacter pylori oncoprotein CagA interaction with beta1 integrin. Proc Natl Acad Sci USA 109:14640-14645.
43. Kim N, Marcus EA, Wen Y, Weeks DL, Scott DR, Jung HC, Song IS, Sachs G. 2004. Genes of Helicobacter pylori regulated by attachment to AGS cells. Infect Immun 72:2358-2368.
44. Kocer B, Ulas M, Ustundag Y, Erdogan S, Karabeyoglu M, Yldrm O, Unal B, Cengiz O, Soran A. 2004. A confirmatory report for the close interaction of Helicobacter pylori with gastric epithelial MUC5AC expression. J Clin Gastroenterol 38:496-502.
45. Lee YY, Derakhsham MH. 2013. Environmental and lifestyle risk factors of gastric cancer. Arch Iran Med 16:358-365.
46. Lillehoj EP, Guang W, Ding H, Czinn SJ, Blanchard TG. 2012. Helicobacter pylori and gastric inflammation: Role of MUC1 mucin. J Pediatr Biochem 2:125-132.
47. Ling F, Wang X, Dai D, Yu M, Chen C, Qian J, Liu C, Zhang Y, Ding J, Guan XW, Shao S. 2013. The Helicobacter pylori protein CagM is located in the transmembrane channel that is required for CagA translocation. Curr Microbiol 67:531-536.
48. Liu JB, Wu XM, Cai J, Zhang JY, Zhang JL, Zhou SH, Shi MX, Qiang FL. 2012. CpG island methylator phenotype and Helicobacter pylori infection associated with gastric cancer. World J Gastroenterol 18:5129-5134.
49. Logan RP, Walker MM. 2001. ABC of the upper gastrointestinal tract: Epidemiology and diagnosis of Helicobacter pylori infection. BMJ 323:920-922.
50. Loh JT, Friedman DB, Piazuelo MB, Bravo LE, Wilson KT, Peek RM, Jr., Correa P, Cover TL. 2012. Analysis of Helicobacter pylori cagA promoter elements required for salt-induced upregulation of CagA expression. Infect Immun 80:3094-3106.
51. Lu XX, Yu JL, Ying LS, Han J, Wang S, Yu QM, Wang XB, Fang XH, Ling ZQ. 2012. Stepwise cumulation of RUNX3 methylation mediated by Helicobacter pylori infection contributes to gastric carcinoma progression. Cancer 118:5507-5517.
52. Machado JC, Nogueira AM, Carneiro F, Reis CA, Sobrinho-Simoes M. 2000. Gastric carcinoma exhibits distinct types of cell differentiation: An immunohistochemical study of trefoil peptides (TFF1 and TFF2) and mucins (MUC1, MUC2, MUC5AC, and MUC6). J Pathol 190:437-443.
53. Maekita T, Nakazawa K, Mihara M, Nakajima T, Yanaoka K, Iguchi M, Arii K, Kaneda A, Tsukamoto T, Tatematsu M, Tamura G, Saito D, Sugimura T, Ichinose M, Ushijima T. 2006. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res 12:989-995.
54. Mahdavi J, Sonden B, Hurtig M, Olfat FO, Forsberg L, Roche N, Angstrom J, Larsson T, Teneberg S, Karlsson KA, Altraja S, Wadstrom T, Kersulyte D, Berg DE, Dubois A, Petersson C, Magnusson KE, Norberg T, Lindh F, Lundskog BB, Arnqvist A, Hammarstrom L, Boren T. 2002. Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science 297:573-578.
55. Manente L, Perna A, Buommino E, Altucci L, Lucariello A, Citro G, Baldi A, Iaquinto G, Tufano MA, De Luca A. 2008. The Helicobacter pylori's protein VacA has direct effects on the regulation of cell cycle and apoptosis in gastric epithelial cells. J Cell Physiol 214:582-587.
56. Marques T, David L, Reis C, Nogueira A. 2005. Topographic expression of MUC5AC and MUC6 in the gastric mucosa infected by Helicobacter pylori and in associated diseases. Pathol Res Pract 201:665-672.
57. Melton SD, Genta RM, Souza RF. 2010. Biomarkers and molecular diagnosis of gastrointestinal and pancreatic neoplasms. Nat Rev Gastroenterol Hepatol 7:620-628.
58. Miehlke S, Kirsch C, Agha-Amiri K, Gunther T, Lehn N, Malfertheiner P, Stolte M, Ehninger G, Bayerdorffer E. 2000. The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in Germany. Int J Cancer 87:322-327.
59. Montecucco C, Papini E, de Bernard M, Zoratti M. 1999. Molecular and cellular activities of Helicobacter pylori pathogenic factors. FEBS Lett 452:16-21.
60. Mueller D, Tegtmeyer N, Brandt S, Yamaoka Y, De Poire E, Sgouras D, Wessler S, Torres J, Smolka A, Backert S. 2012. c-Src and c-Abl kinases control hierarchic phosphorylation and function of the CagA effector protein in Western and East Asian Helicobacter pylori strains. J Clin Invest 122:1553-1566.
61. Nakajima N, Ito Y, Yokoyama K, Uno A, Kinukawa N, Nemoto N, Moriyama M. 2009. The expression of murine double minute 2 (MDM2) on Helicobacter pylori-infected intestinal metaplasia and gastric cancer. J Clin Biochem Nutr 44:196-202.
62. Nam YH, Ryu E, Lee D, Shim HJ, Lee YC, Lee ST. 2011. CagA phosphorylation-dependent MMP-9 expression in gastric epithelial cells. Helicobacter 16:276-283.
63. Nishizawa T, Suzuki H. 2013. The role of microRNA in gastric malignancy. Int J Mol Sci 14:9487-9496.
64. Nomura S, Baxter T, Yamaguchi H, Leys C, Vartapetian AB, Fox JG, Lee JR, Wang TC, Goldenring JR. 2004. Spasmolytic polypeptide expressing metaplasia to preneoplasia in H. felis-infected mice. Gastroenterology 127:582-594.
65. Noritake J, Watanabe T, Sato K, Wang S, Kaibuchi K. 2005. IQGAP1: A key regulator of adhesion and migration. J Cell Sci 118:2085-2092.
66. Noto JM, Peek RM, Jr. 2012. Helicobacter pylori: An overview. Methods Mol Biol 921:7-10.
67. Ogden SR, Wroblewski LE, Weydig C, Romero-Gallo J, O'Brien DP, Israel DA, Krishna US, Fingleton B, Reynolds AB, Wessler S, Peek RM, Jr. 2008. p120 and Kaiso regulate Helicobacter pylori-induced expression of matrix metalloproteinase-7. Mol Biol Cell 19:4110-4121.
68. Osman MA, Bloom GS, Tagoe EA. 2013. Helicobacter pylori-induced alteration of epithelial cell signaling and polarity: a possible mechanism of gastric carcinoma etiology and disparity. Cytoskeleton 70:349-359.
69. O'Toole PW, Lane MC, Porwollik S. 2000. Helicobacter pylori motility. Microbes Infect 2:1207-1214.
70. Parreira P, Magalhaes A, Reis CA, Boren T, Leckband D, Martins MC. 2013. Bioengineered surfaces promote specific protein-glycan mediated binding of the gastric pathogen Helicobacter pylori. Acta Biomater 9:8885-8893.
71. Penta R, De Falco M, Iaquinto G, De Luca A. 2005. Helicobacter pylori and gastric epithelial cells: From gastritis to cancer. J Exp Clin Cancer Res 24:337-345.
72. Perrais M, Rousseaux C, Ducourouble MP, Courcol R, Vincent P, Jonckheere N, Van Seuningen I. 2014. Helicobacter pylori urease and flagellin alter mucin gene expression in human gastric cancer cells. Gastric Cancer 17:235-246.
73. Phadnis SH, Parlow MH, Levy M, Ilver D, Caulkins CM, Connors JB, Dunn BE. 1996. Surface localization of Helicobacter pylori urease and a heat shock protein homolog requires bacterial autolysis. Infect Immun 64:905-912.
74. Pham KT, Weiss E, Jimenez Soto LF, Breithaupt U, Haas R, Fischer W. 2012. CagI is an essential component of the Helicobacter pylori Cag type IV secretion system and forms a complex with CagL. PLoS ONE 7:e35341.
75. Queiroz DM, Silva CI, Goncalves MH, Braga-Neto MB, Fialho AB, Fialho AM, Rocha GA, Rocha AM, Batista SA, Guerrant RL, Lima AA, Braga LL. 2012. Higher frequency of cagA EPIYA-C phosphorylation sites in H. pylori strains from first-degree relatives of gastric cancer patients. BMC Gastroenterol 12:107.
76. Rittmeyer EN, Daniel S, Hsu SC, Osman MA. 2008. A dual role for IQGAP1 in regulating exocytosis. J Cell Sci 121:391-403.
77. Saha A, Hammond CE, Beeson C, Peek RM, Jr., Smolka AJ. 2010. Helicobacter pylori represses proton pump expression and inhibits acid secretion in human gastric mucosa. Gut 59:874-881.
78. Sampieri CL. 2013. Helicobacter pylori and gastritis: The role of extracellular matrix metalloproteases, their inhibitors, and the disintegrins and metalloproteases-A systematic literature review. Dig Dis Sci 58:2777-2783.
79. Schneider S, Weydig C, Wessler S. 2008. Targeting focal adhesions: Helicobacter pylori-host communication in cell migration. Cell Commun Signal 6:2.
80. Shaffer CL, Gaddy JA, Loh JT, Johnson EM, Hill S, Hennig EE, McClain MS, McDonald WH, Cover TL. 2011 Helicobacter pylori exploits a unique repertoire of type IV secretion system components for pilus assembly at the bacteria-host cell interface PLoS Pathog 7:e1002237.
81. Shi D, Qiu XM, Yan XJ. 2014. The changes in MUC5AC expression in gastric cancer before and after Helicobacter pylori eradication. Clin Res Hepatol Gastroenterol 38:235-240.
82. Shiotani A, Cen P, Graham DY. 2013. Eradication of gastric cancer is now both possible and practical. Semin Cancer Biol 23:492-501.
83. Smolka AJ, Backert S. 2012. How Helicobacter pylori infection controls gastric acid secretion. J Gastroenterol 47:609-618.
84. Sun Y, Li JY, He JS, Zhou LX, Chen K. 2005. Tissue microarray analysis of multiple gene expression in intestinal metaplasia, dysplasia and carcinoma of the stomach. Histopathology 46:505-514.
85. Szabo I, Brutsche S, Tombola F, Moschioni M, Satin B, Telford JL, Rappuoli R, Montecucco C, Papini E, Zoratti M. 1999. Formation of anion-selective channels in the cell plasma membrane by the toxin VacA of Helicobacter pylori is required for its biological activity. EMBO J 18:5517-5527.
86. Tamura G, Yin J, Wang S, Fleisher AS, Zou T, Abraham JM, Kong D, Smolinski KN, Wilson KT, James SP, Silverberg SG, Nishizuka S, Terashima M, Motoyama T, Meltzer SJ. 2000. E-cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Nation Cancer Inst 92:569-573.
87. Tegtmeyer N, Wessler S, Backert S. 2011. Role of the cag-pathogenicity island encoded type IV secretion system in Helicobacter pylori pathogenesis. FEBS J 278:1190-1202.
88. Toller IM, Neelsen KJ, Steger M, Hartung ML, Hottiger MO, Stucki M, Kalali B, Gerhard M, Sartori AA, Lopes M, Muller A. 2011. Carcinogenic bacterial pathogen Helicobacter pylori triggers DNA double-strand breaks and a DNA damage response in its host cells. Proc Natl Acad Sci USA 108:14944-14949.
89. Tomb JF, White O, Kerlavage AR, Clayton RA, Sutton GG, Fleischmann RD, Ketchum KA, Klenk HP, Gill S, Dougherty BA, Nelson K, Quackenbush J, Zhou L, Kirkness EF, Peterson S, Loftus B, Richardson D, Dodson R, Khalak HG, Glodek A, McKenney K, Fitzegerald LM, Lee N, Adams MD, Hickey EK, Berg DE, Gocayne JD, Utterback TR, Peterson JD, Kelley JM, Cotton MD, Weidman JM, Fujii C, Bowman C, Watthey L, Wallin E, Hayes WS, Borodovsky M, Karp PD, Smith HO, Fraser CM, Venter JC. 1997. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388:539-547.
90. Tombola F, Carlesso C, Szabo I, de Bernard M, Reyrat JM, Telford JL, Rappuoli R, Montecucco C, Papini E, Zoratti M. 1999. Helicobacter pylori vacuolating toxin forms anion-selective channels in planar lipid bilayers: Possible implications for the mechanism of cellular vacuolation. Biophys J 76:1401-1409.
91. Tsutsumi R, Takahashi A, Azuma T, Higashi H, Hatakeyama M. 2006. Focal adhesion kinase is a substrate and downstream effector of SHP-2 complexed with Helicobacter pylori CagA. Mol Cell Biol 26:261-276.
92. Van de Bovenkamp JH, Mahdavi J, Korteland-Van Male AM, Buller HA, Einerhand AW, Boren T, Dekker J. 2003. The MUC5AC glycoprotein is the primary receptor for Helicobacter pylori in the human stomach. Helicobacter 8:521-532.
93. Van den Brink GR, Tytgat KM, Van der Hulst RW, Van der Loos CM, Einerhand AW, Buller HA, Dekker J. 2000. H. pylori colocalises with MUC5AC in the human stomach Gut 46:601-607.
94. Vanet A, Labigne A. 1998. Evidence for specific secretion rather than autolysis in the release of some Helicobacter pylori proteins. Infect Immun 66:1023-1027.
95. Wang AY, Peura DA. 2011. The prevalence and incidence of Helicobacter pylori-associated peptic ulcer disease and upper gastrointestinal bleeding throughout the world. Gastrointest Endosc Clin N Am 21:613-635.
96. Wang JB, Sonn R, Tekletsadik YK, Samorodnitsky D, Osman MA. 2009. IQGAP1 regulates cell proliferation through a novel CDC42-mTOR pathway. J Cell Sci 122:2024-2033.
97. Wang F, Meng W, Wang B, Qiao L. 2014. Helicobacter pylori-induced gastric inflammation and gastric cancer. Cancer Lett 345:196-202.
98. Weeks DL, Eskandari S, Scott DR, Sachs G. 2000. A H+-gated urea channel: The link between Helicobacter pylori urease and gastric colonization. Science 287:482-485.
99. Wiedemann T, Hofbaur S, Tegtmeyer N, Huber S, Sewald N, Wessler S, Backert S, Rieder G. 2012. Helicobacter pylori CagL dependent induction of gastrin expression via a novel alphavbeta5-integrin-integrin linked kinase signalling complex. Gut 61:986-996.
100. Wroblewski LE, Noble PJ, Pagliocca A, Pritchard DM, Hart CA, Campbell F, Dodson AR, Dockray GJ, Varro A. 2003. Stimulation of MMP-7 (matrilysin) by Helicobacter pylori in human gastric epithelial cells: Role in epithelial cell migration. J Cell Sci 116:3017-3026.
101. Wu CY, Wang CJ, Tseng CC, Chen HP, Wu MS, Lin JT, Inoue H, Chen GH. 2005 Helicobacter pylori promote gastric cancer cells invasion through a NF-kappaB and COX-2-mediated pathway World J Gastroenterol 11:3197-3203.
102. Wu JY, Lu H, Sun Y, Graham DY, Cheung HS, Yamaoka Y. 2006. Balance between polyoma enhancing activator 3 and activator protein 1 regulates Helicobacter pylori-stimulated matrix metalloproteinase 1 expression. Cancer Res 66:5111-5120.
103. Xu X, Liu Z, Fang M, Yu H, Liang X, Li X, Liu X, Chen C, Jia J. 2012. Helicobacter pylori CagA induces ornithine decarboxylase upregulation via Src/MEK/ERK/c-Myc pathway: Implication for progression of gastric diseases. Exp Biol Med 237:435-441.
104. Yamaoka Y, Souchek J, Odenbreit S, Haas R, Arnqvist A, Boren T, Kodama T, Osato MS, Gutierrez O, Kim JG, Graham DY. 2002. Discrimination between cases of duodenal ulcer and gastritis on the basis of putative virulence factors of Helicobacter pylori. J Clin Microbiol 40:2244-2246.